What Researchers Did
This study reviewed the use of hyperbaric oxygen therapy combined with a specific synbiotic supplement to help maintain remission in inflammatory bowel diseases (IBD).
What They Found
The researchers observed that combining hyperbaric oxygenation with the "Normoflorin" synbiotic biocomplex led to improved microbial balance in the gut. They concluded that both the synbiotic and HBOT should be included in treatment programs for IBD patients during the maintenance of remission.
What This Means for Canadian Patients
For Canadian patients managing inflammatory bowel diseases, this research suggests a potential combined approach to support gut health and maintain periods of remission. While more detailed studies are needed, it highlights HBOT as a possible complementary therapy alongside current IBD treatments.
Canadian Relevance
No direct Canadian connection identified. Inflammatory Bowel Diseases is not a Health Canada-recognised indication for HBOT.
Study Limitations
The abstract does not provide specific data, patient numbers, or detailed methodology, making it difficult to fully assess the strength of the findings.